Status:
UNKNOWN
Tumoral Circulating Cells and Colorectal Cancer Progression
Lead Sponsor:
Institut Paoli-Calmettes
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Beckman Coulter, Inc.
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective research of circulating tumor cells as markers of progression risk in colorectal cancer.
Detailed Description
This study aims at allowing a better understanding of which circulating tumor cells (CTC) have the higher risk of metastasis of in the overall population of CTC. Prospective monocenter open-label stu...
Eligibility Criteria
Inclusion
- Patient of more than 18 years old
- Histological diagnosis of colic adenocarcinoma metastatic or not
- Before any treatment with systemic chemotherapy
- Patient affiliated to, or beneficiating of the national security
- Patient having signed informed consent
Exclusion
- Patient with previous chemothrapy treatment
- Patient with more than one evolutive tumoral pathology
- Patient under long-term immunosuppressor treatment
- Patient with severe infection
- Pregnant or breasting woman
- Person in an emergency situation, adult subject to a legal protection measure (a guardian, guardianship or safeguard of justice), or unable of expressing his / her consent.
Key Trial Info
Start Date :
July 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03256084
Start Date
July 17 2017
End Date
May 1 2025
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli Calmettes
Marseille, France, 13009